Cargando…

Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study

Background: Brain atrophy, which is associated with cognitive impairment and retinal nerve fiber layer (RNFL) atrophy, is the main biomarker of neurodegeneration in multiple sclerosis (MS). However, data on the relationship between inflammatory markers, such as oligoclonal bands (OCBs) in the cerebr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giedraitiene, Natasa, Drukteiniene, Egle, Kizlaitiene, Rasa, Cimbalas, Andrius, Asoklis, Rimvydas, Kaubrys, Gintaras
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315759/ https://www.ncbi.nlm.nih.gov/pubmed/34326806 http://dx.doi.org/10.3389/fneur.2021.678735

Ejemplares similares

Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis
por: Giedraitiene, Natasa, et al.
Publicado: (2018)

The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration
por: Giedraitienė, Nataša, et al.
Publicado: (2015)

Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability
por: Giedraitiene, Natasa, et al.
Publicado: (2015)

Detection of aquaporin‐4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania
por: Sakalauskaitė‐Juodeikienė, Eglė, et al.
Publicado: (2018)

Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests
por: Giedraitiene, Natasa, et al.
Publicado: (2019)

Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis
por: Giedraitiene, N., et al.
Publicado: (2020)

Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
por: Makselis, Almantas, et al.
Publicado: (2022)

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
por: Coll‐Martinez, Clàudia, et al.
Publicado: (2021)

Oligoclonal Bands in Multiple System Atrophy: Case Report and Proposed Mechanisms of Immunogenicity
por: Neilson, Lee E., et al.
Publicado: (2022)

Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
por: Kizlaitienandedot, Rasa, et al.
Publicado: (2017)

‘Beta-interferons’ and ‘oligoclonal bands’ in multiple sclerosis in India
por: Hassan, K. M.
Publicado: (2011)

Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients
Publicado: (2015)

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis
por: da Gama, Paulo Diniz, et al.
Publicado: (2015)

Impact of autologous HSCT on the quality of life and fatigue in patients with relapsing multiple sclerosis
por: Giedraitiene, N., et al.
Publicado: (2022)

Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band
por: Vyas, Shikhar G., et al.
Publicado: (2017)

In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses
por: Bankoti, Jaishree, et al.
Publicado: (2014)

Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
por: Leone, Maurizio A., et al.
Publicado: (2013)

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
por: Katsarogiannis, Evangelos, et al.
Publicado: (2023)

Relationship between cognition and treatment adherence to disease-modifying therapy in multiple sclerosis: a prospective, cross-sectional study
por: Giedraitiene, N., et al.
Publicado: (2022)

Distinctive Effect of Donepezil Treatment on P300 and N200 Subcomponents of Auditory Event-Related Evoked Potentials in Alzheimer Disease Patients
por: Vaitkevičius, Arūnas, et al.
Publicado: (2015)

Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis
por: Brecht, Isabel, et al.
Publicado: (2012)

Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients
por: Hümmert, Martin W., et al.
Publicado: (2019)

Oligoclonal Band Straightening Based on Optimized Hierarchical Warping for Multiple Sclerosis Diagnosis
por: Haddad, Farah, et al.
Publicado: (2022)

Quantitative histopathological assessment of ocular surface squamous neoplasia using digital image analysis
por: AŠOKLIS, RIMVYDAS, et al.
Publicado: (2014)

Incidence rate and sex ratio in multiple sclerosis in Lithuania
por: Valadkeviciene, Daiva, et al.
Publicado: (2018)

Comparison of neurophysiological and MRI findings of patients with multiple sclerosis using oligoclonal band technique
por: Ellidag, Hamit Y, et al.
Publicado: (2013)

Oligoclonal Band Status and Features of Radiological and Clinical Findings in Patients with Multiple Sclerosis in Lithuania
por: Aleksandravičiūtė, Emilija, et al.
Publicado: (2023)

Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi
por: Berek, Klaus, et al.
Publicado: (2020)

Changes in macular thickness after trabeculectomy with or without adjunctive 5-fluorouracil
por: Kadziauskienė, Aistė, et al.
Publicado: (2017)

Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles
por: Mero, Inger-Lise, et al.
Publicado: (2013)

Detection of Oligoclonal Ig Bands: Clinical Significance and Trends in Methodological Improvement
por: Trbojevic–Cepe, Milica
Publicado: (2004)

Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases
por: Pannewitz-Makaj, Katharina, et al.
Publicado: (2020)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
por: Klose, Veronika, et al.
Publicado: (2023)

Properties of odor identification testing in screening for early-stage Alzheimer’s disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Olfactory memory in mild cognitive impairment and Alzheimer’s disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Odor Discrimination as a Marker of Early Alzheimer’s Disease
por: Audronyte, Egle, et al.
Publicado: (2023)

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2018)

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome
por: Makhani, Naila, et al.
Publicado: (2019)

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
por: Ferraro, Diana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vs2ov4midsd3d2r54fqsn8v5p4